Adalimumab is an immunosuppressive medication that belongs to a class of drugs known as TNF (Tumor Necrosis Factor) blockers. It is usually prescribed to people who experience some types of autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage). Some examples of the disorders are arthritis diseases (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis) and certain skin diseases (such as plaque-type psoriasis and hidradenitis suppurativa).